Anti-proliferative and angio-suppressive effect of Stoechospermum marginatum (C. Agardh) Kutzing extract using various experimental models

다국어 초록 (Multilingual Abstract)

BACKGROUND/OBJECTIVES: Abundant consumption of seaweeds in the diet is epidemiologically linked to the reduction in risk of developing cancer. In larger cases, however, identification of particular seaweeds that are accountable for these effects is still lacking, hindering the recognition of competent dietary-based chemo preventive approaches. The aim of this research was to establish the antiproliferative potency and angiosuppressive mode of action of Stoechospermum marginatum seaweed methanolic extract using various experimental models.
MATERIALS/METHODS: Among the 15 seaweeds screened for antiproliferative activity against Ehrlich ascites tumor (EAT) cell line, Stoechospermum marginatum extract (SME) was found to be the most promising. Therefore, it was further investigated for its anti-proliferative activity in-vitro against choriocarcinoma (BeWo) and non-transformed Human embryonic kidney (HEK 293) cells, and for its anti-migratory/tube formation activity against HUVEC cells in-vitro. Subsequently, the angiosuppressive activity of S. marginatum was established by inhibition of angiogenesis in in-vivo (peritoneal angiogenesis and chorioallantoic membrane assay) and ex-vivo (rat cornea assay) models.
RESULTS: Most brown seaweed extracts inhibited the proliferation of EAT cells, while green and red seaweed extracts were much less effective. According to the results, SME selectively inhibited proliferation of BeWo cells in-vitro in a dose-dependent manner, but had a lesser effect on HEK 293 cells. SME also suppressed the migration and tube formation of HUVEC cells in-vitro. In addition, SME was able to suppress VEGF-induced angiogenesis in the chorio allantoic membrane, rat cornea, and tumor induced angiogenesis in the peritoneum of EAT bearing mice. A decrease in the microvessel density count and CD31 antigen staining of treated mice peritoneum provided further evidence of its angiosuppressive activity.
CONCLUSIONS: Altogether, the data underline that VEGF mediated angiogenesis is the target for the angiosuppressive action of SME and could potentially be useful in cancer prevention or treatment involving stimulated angiogenesis.

목차 (Table of Contents)

• INTRODUCTION
• MATERIAL AND METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Folkman J, "What is the evidence that tumors are angiogenesis dependent?" 82 : 4-6, 1990

2 Nussenbaum F, "Tumor angiogenesis: insights and innovations" 2010 : 132641-, 2010

3 Birner P, "Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer" 7 : 93-97, 2001

4 Kotnala S, "Screening for the presence of antimicrobial activity in few Indian seaweeds" 32 : 69-75, 2009

5 Mesiano S, "Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization" 153 : 1248-1256, 1998

6 Wang YD, "Relationship between vascular invasion and microvessel density and micrometastasis" 13 : 6269-6273, 2007

7 Folkman J, "Relation of vascular proliferation to tumor growth" 16 : 207-248, 1976

8 Miller KD, "Redefining the target: chemotherapeutics as antiangiogenics" 19 : 1195-1206, 2001

9 Hanahan D, "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis" 86 : 353-364, 1996

10 Marwick C, "Natural compounds show antiangiogenic activity" 93 : 1685-, 2001

11 Smit AJ, "Medicinal and pharmaceutical uses of seaweed natural products: a review" 16 : 245-262, 2004

12 Carmeliet P, "Mechanisms of angiogenesis and arteriogenesis" 6 : 389-395, 2000

13 Hanahan D, "Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice" 105 : 1045-1047, 2000

14 Kim KJ, "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo" 362 : 841-844, 1993

15 Sarayba MA, "Inhibition of corneal neovascularization by a peroxisome proliferatoractivated receptor-gamma ligand" 80 : 435-442, 2005

16 Liang CC, "In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro" 2 : 329-333, 2007

17 Chandini SK, "In vitro antioxidant activities of three selected brown seaweeds of India" 107 : 707-713, 2008

18 Ye J, "Enzyme-digested fucoidan extracts derived from seaweed Mozuku of Cladosiphon novae-caledoniae kylin inhibit invasion and angiogenesis of tumor cells" 47 : 117-126, 2005

19 Cai H, "Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress" 87 : 840-844, 2000

20 Matsubara K, "Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells" 15 : 695-699, 2005

21 Madhusudan S, "Drug inhibition of angiogenesis" 2 : 403-414, 2002

22 Naderali EK, "Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols" 101 : 499-506, 2001

23 Klement G, "Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity" 105 : R15-R24, 2000

24 Borgström P, "Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy" 56 : 4032-4039, 1996

25 Kerbel R, "Clinical translation of angiogenesis inhibitors" 2 : 727-739, 2002

26 Ribatti D, "Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo" 264 : 317-324, 2001

27 Sugawara T, "Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice" 132 : 946-951, 2002

28 Devi KP, "Bioprotective properties of seaweeds: in vitro evaluation of antioxidant activity and antimicrobial activity against food borne bacteria in relation to polyphenolic content" 8 : 38-, 2008

29 Tanghetti E, "Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts" 21 : 3889-3897, 2002

30 Vinayak RC, "Bio-screening of a few green seaweeds from India for their cytotoxic and antioxidant potential" 91 : 2471-2476, 2011

31 Vinayak RC, "Bio-prospecting of a few brown seaweeds for their cytotoxic and antioxidant activities" 2011 : 673083-, 2011

32 Vinayak RC, "Bio-evaluation of two red seaweeds for their cytotoxic and antioxidant activities in vitro" 7 : 2010

33 Ganesan P, "Antioxidant properties of methanol extract and its solvent fractions obtained from selected Indian red seaweeds" 99 : 2717-2723, 2008

34 Kumar KS, "Antioxidant potential of solvent extracts of Kappaphycus alvarezii (Doty) Doty - an edible seaweed" 107 : 289-295, 2008

35 Sithranga Boopathy N, "Anticancer drugs from marine flora: an overview" 2010 : 214186-, 2010

36 Keshet E, "Anticancer drug targets: approaching angiogenesis" 104 : 1497-1501, 1999

37 Browder T, "Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer" 60 : 1878-1886, 2000

38 Matsubara K, "Antiangiogenic properties of a sulfated galactan isolated from a marine green alga, Codium cylindricum" 15 : 87-90, 2003

39 Mojzis J, "Antiangiogenic effects of flavonoids and chalcones" 57 : 259-265, 2008

40 Gururaj AE, "Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation" 243 : 107-112, 2003

41 Deepak AV, "Antiangiogenic and proapoptotic activity of a novel glycoprotein from U. indica is mediated by NF-kappaB and Caspase activated DNase in ascites tumor model" 88 : 297-307, 2006

42 Guerra Dore CM, "Antiangiogenic activity and direct antitumor effect from a sulfated polysaccharide isolated from seaweed" 88 : 12-18, 2013

43 Sheela ML, "Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra" 6 : 494-498, 2006

44 Gupta K, "Angiogenesis: a curse or cure?" 81 : 236-242, 2005

45 Folkman J, "Angiogenesis in cancer, vascular, rheumatoid and other disease" 1 : 27-31, 1995

46 Folkman J, "Angiogenesis" 267 : 10931-10934, 1992

47 Dias PF, "A polysaccharide isolated from the brown seaweed Sargassum stenophyllum exerts antivasculogenic effects evidenced by modified morphogenesis" 75 : 34-44, 2008